Steven P. Rowe MD, PhDAssociate Professor of Radiology, Urology, and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Dr. Rowe completed residency training in radiology and nuclear medicine at Johns Hopkins University School of Medicine, subsequently joining the faculty there in 2016. Since that time, he has been engaged in research focused on molecular imaging of genitourinary malignancies. His focus has included prostate-specific membrane antigen (PSMA) positron emission tomography (PET) for prostate cancer and renal cell carcinoma, as well as the use of non-invasive methods to improve risk stratification in patients with indeterminate renal masses. He is currently actively interested in projects at the crossroads of molecular imaging and artificial intelligence.
Dr. Rowe has a consulting agreement with and receives research funding from Lantheus Medical Imaging/Progenics Pharmaceuticals. He has a consulting agreement with, has equity in, and receives research funding from Precision Molecular, Inc. He has equity in and receives research funding from PlenaryAI, Inc.
Recent Contributions to PracticeUpdate:
- 68a-PSMA PET/CT and Multiparametric MRI vs Totally Embedded Radical Prostatectomy in the Diagnosis and Management of Prostate Cancer
- MIBI Imaging for the Evaluation and Risk Stratification of Renal Masses
- (68) Ga-PSMA Has a High Detection Rate of Prostate Cancer Recurrence Outside the Prostatic Fossa